JPS6320409B2 - - Google Patents
Info
- Publication number
- JPS6320409B2 JPS6320409B2 JP17386680A JP17386680A JPS6320409B2 JP S6320409 B2 JPS6320409 B2 JP S6320409B2 JP 17386680 A JP17386680 A JP 17386680A JP 17386680 A JP17386680 A JP 17386680A JP S6320409 B2 JPS6320409 B2 JP S6320409B2
- Authority
- JP
- Japan
- Prior art keywords
- bisacodyl
- solid composition
- dioctyl sulfosuccinate
- sodium dioctyl
- tablets
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 36
- KHOITXIGCFIULA-UHFFFAOYSA-N Alophen Chemical compound C1=CC(OC(=O)C)=CC=C1C(C=1N=CC=CC=1)C1=CC=C(OC(C)=O)C=C1 KHOITXIGCFIULA-UHFFFAOYSA-N 0.000 claims description 34
- 229960000503 bisacodyl Drugs 0.000 claims description 33
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 claims description 25
- YHAIUSTWZPMYGG-UHFFFAOYSA-L disodium;2,2-dioctyl-3-sulfobutanedioate Chemical compound [Na+].[Na+].CCCCCCCCC(C([O-])=O)(C(C([O-])=O)S(O)(=O)=O)CCCCCCCC YHAIUSTWZPMYGG-UHFFFAOYSA-L 0.000 claims description 21
- 239000008247 solid mixture Substances 0.000 claims description 18
- 239000003826 tablet Substances 0.000 claims description 17
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 9
- 235000002906 tartaric acid Nutrition 0.000 claims description 9
- 239000011975 tartaric acid Substances 0.000 claims description 9
- 239000008187 granular material Substances 0.000 claims description 7
- 150000007524 organic acids Chemical class 0.000 claims description 6
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 4
- 239000008298 dragée Substances 0.000 claims description 4
- 239000007940 sugar coated tablet Substances 0.000 claims description 4
- 239000007902 hard capsule Substances 0.000 claims description 3
- 239000002662 enteric coated tablet Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 description 12
- 239000003814 drug Substances 0.000 description 10
- 229940079593 drug Drugs 0.000 description 9
- 239000000203 mixture Substances 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- 239000004094 surface-active agent Substances 0.000 description 7
- 206010010774 Constipation Diseases 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 229920002261 Corn starch Polymers 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 5
- 239000008116 calcium stearate Substances 0.000 description 5
- 235000013539 calcium stearate Nutrition 0.000 description 5
- 239000001913 cellulose Substances 0.000 description 5
- 229920002678 cellulose Polymers 0.000 description 5
- 239000008120 corn starch Substances 0.000 description 5
- 229940099112 cornstarch Drugs 0.000 description 5
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 5
- 230000007062 hydrolysis Effects 0.000 description 5
- 238000006460 hydrolysis reaction Methods 0.000 description 5
- CDOUZKKFHVEKRI-UHFFFAOYSA-N 3-bromo-n-[(prop-2-enoylamino)methyl]propanamide Chemical compound BrCCC(=O)NCNC(=O)C=C CDOUZKKFHVEKRI-UHFFFAOYSA-N 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 239000012086 standard solution Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 230000013872 defecation Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 210000004347 intestinal mucosa Anatomy 0.000 description 3
- 238000004898 kneading Methods 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- 235000010981 methylcellulose Nutrition 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 238000004513 sizing Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229930185605 Bisphenol Natural products 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000009505 enteric coating Methods 0.000 description 1
- 239000002702 enteric coating Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 150000007519 polyprotic acids Polymers 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000007391 self-medication Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
Landscapes
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17386680A JPS5799521A (en) | 1980-12-11 | 1980-12-11 | Solid composition containing bisacodyl |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17386680A JPS5799521A (en) | 1980-12-11 | 1980-12-11 | Solid composition containing bisacodyl |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5799521A JPS5799521A (en) | 1982-06-21 |
| JPS6320409B2 true JPS6320409B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1988-04-27 |
Family
ID=15968579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP17386680A Granted JPS5799521A (en) | 1980-12-11 | 1980-12-11 | Solid composition containing bisacodyl |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5799521A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5914132A (en) * | 1993-02-26 | 1999-06-22 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery |
| US5651983A (en) * | 1993-02-26 | 1997-07-29 | The Procter & Gamble Company | Bisacodyl dosage form for colonic delivery |
| CZ286051B6 (cs) * | 1993-02-26 | 1999-12-15 | The Procter & Gamble Company | Farmaceutický prostředek a způsob jeho použití pro dasažení projímavého účinku |
| US5843479A (en) * | 1993-02-26 | 1998-12-01 | The Procter & Gamble Company | Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery |
| JP4705747B2 (ja) * | 2001-05-30 | 2011-06-22 | ユーロセルティック ソシエテ アノニム | 薬剤組成物 |
| AU2003262060A1 (en) * | 2002-09-10 | 2004-04-30 | Taisho Pharmaceutical Co., Ltd. | Solid preparation containing dioctyl sodium sulfosuccinate |
| JP2004123731A (ja) * | 2002-09-10 | 2004-04-22 | Taisho Pharmaceut Co Ltd | ジオクチルソジウムスルホサクシネート配合錠剤 |
| AU2005221457B2 (en) * | 2004-03-10 | 2010-08-12 | Taisho Pharmaceutical Co., Ltd. | Poorly water-soluble drug-containing solid formulation |
| JP2005255595A (ja) * | 2004-03-10 | 2005-09-22 | Taisho Pharmaceut Co Ltd | ジオクチルソジウムスルホサクシネート配合錠剤 |
| KR100632431B1 (ko) | 2005-02-25 | 2006-10-11 | 보람제약주식회사 | 하제 투명액제의 연질캡슐, 그 조성물 및 제조방법 |
-
1980
- 1980-12-11 JP JP17386680A patent/JPS5799521A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5799521A (en) | 1982-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR0135289B1 (ko) | 제약학적 과립 | |
| JP2720932B2 (ja) | 経口投与用アセトアミノフエン錠剤の製造法及びアセトアミノフエン二層錠剤 | |
| US3148124A (en) | Method of preparing sustained release pharmaceutical tablets | |
| KR960005140B1 (ko) | 서방성 매트릭스 제형 | |
| KR100202154B1 (ko) | 파라세타몰 및 돔페리돈을 함유한 필름 피복 정제 | |
| JPH05112445A (ja) | 作用開始を速くし潜在特性を増加させる移送システム | |
| JPH0122245B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| HU228498B1 (en) | Formulation of fast-dissolving efavirenz capsules or tablets and process for the preparation thereof | |
| JP2609022B2 (ja) | ポリカルボフィルカルシウム含有製剤 | |
| JPH09504280A (ja) | センナ剤形 | |
| EP0159852A2 (en) | Directly compressible pharmaceutical compositions | |
| CN101626755B (zh) | 包含酸不稳定药物的双单元片剂 | |
| JPS6320409B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| JPH0774153B2 (ja) | ロキソプロフェン・ナトリウム含有製剤 | |
| WO1997033574A1 (fr) | Comprimes a liberation prolongee a base de valproate metallique | |
| US4601895A (en) | Delayed-action acetylsalicylic acid formulations for oral administration | |
| EP0324725B1 (en) | A pharmaceutical composition | |
| CA2517120C (en) | Pharmaceutical composition containing platinum complex as active substance and method of manufacturing thereof | |
| JPH03120257A (ja) | 骨形成促進剤 | |
| JPH08198761A (ja) | ポリカルボフィルカルシウム含有製剤 | |
| KR100267525B1 (ko) | 시타라빈 옥포스페이트 경질 캡슐제 | |
| JP4370050B2 (ja) | クラリスロマイシン錠剤およびその製造法 | |
| JP2669517B2 (ja) | ロキソプロフェン・ナトリウム含有固形製剤 | |
| US6555137B1 (en) | Sucralfate-containing composition and process for the preparation thereof | |
| GB2061111A (en) | Long acting pharmaceutical composition |